EP3274352
HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.3.2016EP published:
2.1.2019EP application number:
16710764.8
EPO information:
European Patent Register
Max expiry date:
20.3.2036
Title:
HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR
Timeline
Today
21.3.2016EP application
2.1.2019EP Publication
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353, Berlin, DE
Inventor
Name:
HÄRTER, MichaelAddress:
Leverkusen, DE
Name:
KOSEMUND, DirkAddress:
Berlin, DE
Name:
DELBECK, MartinaAddress:
Heiligenhaus, DE
Name:
KALTHOF, BerndAddress:
Wuppertal, DE
Name:
WASNAIRE, PierreAddress:
Düsseldorf, DE
Name:
SÜSSMEIER, FrankAddress:
München, DE
Name:
LUSTIG, KlemensAddress:
Wuppertal, DE
Priority
Number:
15161165Date:
26.3.2015Country:
EP
Number:
15174566Date:
30.6.2015Country:
EP
Number:
15184732Date:
10.9.2015Country:
EP
Classification
Categories:
C07D 495/04, A61K 31/519, A61P 37/00, A61P 35/00, A61P 11/00